Diuretics in heart failure

Batlle DC, Von Riotte AB, Gaviria M, Grupp M (1985) Amelioration of polyuria by amiloride in patients receiving long-term lithium therapy. N Engl J Med 312:408–414

Bock HA, Stein JH (1988) Diuretics and the control of extracellular fluid volume: role of counterregulation. Semin Nephrol 8:264–272

Brater DC (1998) Diuretic therapy. N Engl J Med 339:387–395

Brilla CG, Matsubara LS, Weber KT (1993) Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension. Am J Cardiol 71:12A–16A

Cooper HA, Dries DL, Davis CE et al (1999) Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction. Circulation 100:1311–1315

Costanzo MR, Guglin ME, Saltzberg MT et al (2007) Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 49:675–683

Dai LJ, Friedman PA, Quamme GA (1997) Cellular mechanisms of chlorothiazide and cellular potassium depletion on Mg2+ uptake in mouse distal convoluted tubule cells. Kidney Int 51:1008–1017

Dickstein K, Cohen-Solal A, Filippatos G et al (2008) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 29:2388–2442

Domanski M, Norman J, Pitt B et al (2003) Diuretic use, progressive heart failure and death in patients in the Studies Of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 42:705–708

Dyckner T, Wester PO, Widman L (1988) Amiloride prevents thiazide-induced intracellular potassium and magnesium losses. Acta Med Scand 224:25–30

Elliott WJ, Meyer PM (2007) Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis. Lancet 369:201–207

Ellison DH (1991) The physiologic basis of diuretic synergism: its role in treating diuretic resistance. Ann Intern Med 114:886–894

Fliser D, Haller H (2004) Modern differential therapy with diuretics. Internist (Berl) 45:598–605

Galve E, Mallol A, Catalan R et al (2005) Clinical and neurohumoral consequences of diuretic withdrawal in patients with chronic, stabilized heart failure and systolic dysfunction. Eur J Heart Fail 7:892–898

Hawkins RG, Houston MC (2005) Is population-wide diuretic use directly associated with the incidence of end-stage renal disease in the United States? A hypothesis. Am J Hypertens 18:744–749

Higgins BA, Nassim JR, Collins J, Hilb A (1964) The effect of bendrofluazide on urine calcium excretion. Clin Sci 27:457–462

Huen SC, Goldfarb DS (2007) Adverse metabolic side effects of thiazides: implications for patients with calcium nephrolithiasis. J Urol 177:1238–1243

Kagan A, Rapoport J (2005) The role of peritoneal dialysis in the treatment of refractory heart failure. Nephrol Dial Transplant 20(suppl 7):vii28–31

Karalliedde J, Buckingham RE (2007) Thiazolidinediones and their fluid-related adverse effects: facts, fiction and putative management strategies. Drug Saf 30:741–753

Klamerus KJ (1986) Current concepts in clinical therapeutics: congestive heart failure. Clin Pharm 5:481–498

Knauf H, Mutschler E (1984) Pharmacodynamics and pharmacokinetics of xipamide in patients with normal and impaired kidney function. Eur J Clin Pharmacol 26:513–520

Konig P, Geissler D, Lechleitner P et al (1987) Improved management of congestive heart failure. Use of continuous ambulatory peritoneal dialysis. Arch Intern Med 147:1031–1034

Lassnigg A, Donner E, Grubhofer G et al (2000) Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. J Am Soc Nephrol 11:97–104

Law MR, Wald NJ, Morris JK, Jordan RE (2003) Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ 326:1427

Lehrich RW, Greenberg A (2008) When is it appropriate to use vasopressin receptor antagonists? J Am Soc Nephrol 19:1054–1058

Loon NR, Wilcox CS, Unwin RJ (1989) Mechanism of impaired natriuretic response to furosemide during prolonged therapy. Kidney Int 36:682–689

Maronde RF, Milgrom M, Vlachakis ND, Chan L (1983) Response of thiazide-induced hypokalemia to amiloride. JAMA 249:237–241

Mccurley JM, Hanlon SU, Wei SK et al (2004) Furosemide and the progression of left ventricular dysfunction in experimental heart failure. J Am Coll Cardiol 44:1301–1307

Mehta RL, Pascual MT, Soroko S, Chertow GM (2002) Diuretics, mortality and nonrecovery of renal function in acute renal failure. JAMA 288:2547–2553

Nieminen MS, Bohm M, Cowie MR et al (2005) Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 26:384–416

Perez AV, Dietz R, Rauchhaus M (2008) Are diuretics overused in the treatment of chronic heart failure? Nat Clin Pract 5:238–239

Philipp T (2008) Diuretika. In: Wolff-Weihrauch (Hrsg) Internistische Therapie. Elsevier, Amsterdam, p 147–160

Ram CV, Garrett BN, Kaplan NM (1981) Moderate sodium restriction and various diuretics in the treatment of hypertension. Arch Intern Med 141:1015–1019

Ronco C, Haapio M, House AA et al (2008) Cardiorenal syndrome. J Am Coll Cardiol 52:1527–1539

Salvador DR, Rey NR, Ramos GC, Punzalan FE (2004) Continuous infusion versus bolus injection of loop diuretics in congestive heart failure. Cochrane Database Syst Rev:CD003178

Sandhofer A, Kahler C, Heininger D et al (2002) Severe electrolyte disturbances and renal failure in elderly patients with combined diuretic therapy including xipamid. Wien Klin Wochenschr 114:938–942

Schneider D, Richling F (2008) Checkliste Arzneimittel A–Z. Thieme, Stuttgart

Schrier RW, Gross P, Gheorghiade M et al (2006) Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med 355:2099–2112

Swedberg K, Cleland J, Dargie H et al (2005) Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 26:1115–1140

Velazquez H (1987) Thiazide diuretics. Ren Physiol 10:184–197

Verdel BM, van Puijenbroek EP, Souverein PC et al (2008) Drug-related nephrotoxic and ototoxic reactions: a link through a predictive mechanistic commonality. Drug Saf 31:877–884

Wenzel RR (2006) Role of angiotensin-1-receptor blockers in cardiorenal disease. Curr Drug Ther 1:47–54

Wenzel RR, Bruck H, Noll G et al (2000) Antihypertensive drugs and the sympathetic nervous system. J Cardiovasc Pharmacol 35:S43–S52

Bagshaw SM, Brophy PD, Cruz D, Ronco C (2008) Fluid balance as a biomarker: impact of fluid overload on outcome in critically ill patients with acute kidney injury. Crit Care 12:169

Sica DA, Nephron Gehr TW (1989) Triamterene and the kidney. Nephron 51:454–461